Mehnert, J. M., Lee, S. J., Gastman, B., Hsu, C. C., Cohen, G. I., Eicher, D. M., Funchain, P., Miller, D. M., Silk, A. W., Wuthrick, E. J., Wolchok, J. D., Chakravarthy, A. B., Kirkwood, J. M. (2026). Updated outcomes from STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab, a phase III trial—ECOG-ACRIN EA6174.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba9505